| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
SRY-box transcription factor 9 | 0.419 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
potassium voltage-gated channel subfamily A regulatory beta subunit 2 | 0.593 | 0.692 | 0.80 |
|
phenotype | 0.100 | None | 0 | 0 | |||||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
natural cytotoxicity triggering receptor 3 | 0.638 | 0.769 | 3.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
long intergenic non-protein coding RNA 243 | 0.729 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
mediator of DNA damage checkpoint 1 | 0.628 | 0.692 | 2.3E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 3 | 0.641 | 0.346 | 8.5E-07 |
|
disease | 0.790 | strong | 1.000 | 9 | 4 | 1994 | 2018 | ||||||||
|
DEAF1 transcription factor | 0.575 | 0.615 | 3.4E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2017 | 2017 | ||||||||
|
clusterin associated protein 1 | 0.805 | 0.231 | 4.2E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
kynureninase | 0.617 | 0.692 | 4.2E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | 0.610 | 0.692 | 2.5E-16 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 | 0.534 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ceramide transporter 1 | 0.674 | 0.500 | 0.67 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
EBP cholestenol delta-isomerase | 0.494 | 0.846 | 0.94 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
thioredoxin like 4A | 0.711 | 0.385 | 7.2E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
midline 2 | 0.695 | 0.500 | 0.18 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RNA polymerase III subunit A | 0.538 | 0.769 | 1.3E-23 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
interleukin 1 receptor accessory protein like 1 | 0.617 | 0.692 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
mannosidase alpha class 1B member 1 | 0.606 | 0.577 | 1.2E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAB39B, member RAS oncogene family | 0.619 | 0.615 | 0.83 |
|
disease | 0.100 | None | 0 | 0 |